Neoplasms
|
0.070 |
AlteredExpression
|
group |
BEFREE |
There are several RAP80/UIMC1 isoforms that are predominantly expressed in testis, however we did not observe elevated expression of these transcripts in tumors from seropositive patients.
|
17562356 |
2007 |
Malignant Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
Sera from 5% to 10% of patients with different types of cancer contain specific antibodies to RAP80/UIMC1.
|
17562356 |
2007 |
Primary malignant neoplasm
|
0.020 |
Biomarker
|
group |
BEFREE |
Sera from 5% to 10% of patients with different types of cancer contain specific antibodies to RAP80/UIMC1.
|
17562356 |
2007 |
Colonic Neoplasms
|
0.010 |
AlteredExpression
|
group |
BEFREE |
The majority of RAP80/UIMC1 transcripts was detected both in normal tissues and in colon tumors.
|
17562356 |
2007 |
Malignant neoplasm of breast
|
0.060 |
Biomarker
|
disease |
BEFREE |
Our analysis suggests that RAP80 and CCDC98 do not play an important role as high penetrance breast cancer susceptibility genes.
|
18270812 |
2009 |
Breast Carcinoma
|
0.060 |
Biomarker
|
disease |
BEFREE |
Our analysis suggests that RAP80 and CCDC98 do not play an important role as high penetrance breast cancer susceptibility genes.
|
18270812 |
2009 |
Breast Cancer, Familial
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Evaluation of the BRCA1 interacting genes RAP80 and CCDC98 in familial breast cancer susceptibility.
|
18270812 |
2009 |
ovarian neoplasm
|
0.010 |
GeneticVariation
|
disease |
LHGDN |
Evaluation of the BRCA1 interacting genes RAP80 and CCDC98 in familial breast cancer susceptibility.
|
18270812 |
2009 |
Malignant neoplasm of breast
|
0.060 |
GeneticVariation
|
disease |
BEFREE |
A novel RAP80 haplotype or rare missense mutations may be associated with a modest increased risk of breast cancer, but this observation needs to be confirmed by additional studies.
|
18306035 |
2009 |
Breast Carcinoma
|
0.060 |
GeneticVariation
|
disease |
BEFREE |
A novel RAP80 haplotype or rare missense mutations may be associated with a modest increased risk of breast cancer, but this observation needs to be confirmed by additional studies.
|
18306035 |
2009 |
Breast Cancer, Familial
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
In summary, we did not find truncating mutations of the RAP80 gene to be a cause of familial breast cancer.
|
18306035 |
2009 |
Mammary Neoplasms
|
0.010 |
GeneticVariation
|
group |
LHGDN |
Germline RAP80 mutations and susceptibility to breast cancer.
|
18306035 |
2009 |
Malignant neoplasm of breast
|
0.060 |
GeneticVariation
|
disease |
BEFREE |
Conclusions Overall, it seems unlikely that moderate to highly penetrant alleles of either RAP80 or Abraxas, confer a significantly high relative risk of breast cancer.
|
18695986 |
2009 |
Breast Carcinoma
|
0.060 |
GeneticVariation
|
disease |
BEFREE |
Conclusions Overall, it seems unlikely that moderate to highly penetrant alleles of either RAP80 or Abraxas, confer a significantly high relative risk of breast cancer.
|
18695986 |
2009 |
Malignant Neoplasms
|
0.020 |
GeneticVariation
|
group |
BEFREE |
Although evidently quite rare, these results suggest that critical constitutional mutations in RAP80 abrogate DDR function and may be involved in genetic predisposition to cancer.
|
19305427 |
2009 |
Primary malignant neoplasm
|
0.020 |
GeneticVariation
|
group |
BEFREE |
Although evidently quite rare, these results suggest that critical constitutional mutations in RAP80 abrogate DDR function and may be involved in genetic predisposition to cancer.
|
19305427 |
2009 |
Congenital chromosomal disease
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Compared with wild-type RAP80, expression of the delE81 allele was associated with a significant increase in cytogenetically detectable chromosomal aberrations, particularly chromatid breaks.
|
19305427 |
2009 |
Age at menopause
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Genome-wide association studies identify loci associated with age at menarche and age at natural menopause.
|
19448621 |
2009 |
Age at menopause
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide association studies identify loci associated with age at menarche and age at natural menopause.
|
19448621 |
2009 |
Malignant neoplasm of breast
|
0.060 |
Biomarker
|
disease |
BEFREE |
Mutation screening of the MERIT40 gene encoding a novel BRCA1 and RAP80 interacting protein in breast cancer families.
|
19572197 |
2010 |
Breast Carcinoma
|
0.060 |
Biomarker
|
disease |
BEFREE |
Mutation screening of the MERIT40 gene encoding a novel BRCA1 and RAP80 interacting protein in breast cancer families.
|
19572197 |
2010 |
Neoplasms
|
0.070 |
AlteredExpression
|
group |
BEFREE |
Quantitative PCR or immunohistochemistry were used to analyze the expression of β-tubuline IIA (TUBB2A), β-tubuline III (TUBB3), BRCA1, ERCC1, Abraxas (ABRX) and RAP80 in mRNA isolated from paraffin-embedded tumor biopsies of 45 NSCLC patients treated as part of a larger observational trial.
|
21529986 |
2011 |
Non-Small Cell Lung Carcinoma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Tubulin, BRCA1, ERCC1, Abraxas, RAP80 mRNA expression, p53/p21 immunohistochemistry and clinical outcome in patients with advanced non small-cell lung cancer receiving first-line platinum-gemcitabine chemotherapy.
|
21529986 |
2011 |
Age at menopause
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways.
|
22267201 |
2012 |
Age at menopause
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways.
|
22267201 |
2012 |